Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

Every morning, to avoid getting sick, Jessica Baudean must take a long trip across the Mississippi. Baudean, who is disabled, ...

The Trump administration’s abrupt shift in federal funding has reached into Louisiana’s research institutions.

Source: Chinaka border area identified as HIV, child exploitation high-risk zone –Newsday Zimbabwe The revelation was made ...

Over 1,200 individuals gathered at Kapiʻolani Park on June 21 to participate in the 34th annual Walk for Life, Honolulu’s ...

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

The LGBTQIA+ community and supporters participated in this year’s Honolulu AIDS Walk on Saturday to raise awareness about the ...

The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...